| 2025年中报 | 2024年年报 | 2024年中报 | 2023年年报 | 2023年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 分部间抵销(元) | -1,454,993.15 | - | -1,616,712.69 | - | -1,328,857.17 |
| 药品制剂(元) | 1,537,335,360.67 | - | 1,543,072,347.68 | - | 1,515,167,497.87 |
| 医疗器械(元) | 98,090,882.50 | 222,570,757.11 | 114,039,782.23 | 233,400,261.36 | 115,970,065.24 |
| 妇科用药(元) | - | 92,554,770.15 | - | 84,070,373.83 | - |
| 精神神经系统类(元) | - | 156,796,362.59 | - | 138,768,292.17 | - |
| 慢性肾病类(元) | - | 383,571,586.05 | - | 388,459,394.44 | - |
| 皮肤病类(元) | - | 428,828,205.02 | - | 382,765,569.85 | - |
| 糖尿病类(元) | - | 471,375,700.82 | - | 418,443,893.53 | - |
| 消化系统类(元) | - | 469,663,073.52 | - | 438,454,579.22 | - |
| 心血管类(元) | - | 896,624,016.25 | - | 940,815,337.79 | - |
| 其他(元) | - | 2,044,289.17 | - | 3,053,330.80 | - |
| 其他治疗领域(元) | - | 309,251,202.29 | - | 299,432,244.80 | - |
| 营业成本(元) | |||||
| 分部间抵销(元) | -1,404,534.44 | - | -1,561,666.81 | - | -1,328,857.17 |
| 药品制剂(元) | 493,393,154.87 | - | 493,113,378.44 | - | 457,679,023.01 |
| 医疗器械(元) | 55,557,493.60 | 116,235,671.05 | 59,840,444.96 | 124,912,618.81 | 64,264,957.04 |
| 妇科用药(元) | - | 31,755,619.48 | - | 27,560,871.27 | - |
| 精神神经系统类(元) | - | 25,708,711.39 | - | 23,307,653.81 | - |
| 慢性肾病类(元) | - | 141,530,036.40 | - | 152,799,144.66 | - |
| 皮肤病类(元) | - | 198,536,775.86 | - | 182,839,009.15 | - |
| 糖尿病类(元) | - | 79,433,190.99 | - | 65,538,408.35 | - |
| 消化系统类(元) | - | 230,898,534.62 | - | 217,759,975.56 | - |
| 心血管类(元) | - | 162,086,556.33 | - | 154,834,913.53 | - |
| 其他(元) | - | 732,645.26 | - | 4,401,020.91 | - |
| 其他治疗领域(元) | - | 145,190,903.45 | - | 153,794,872.53 | - |
| 毛利(元) | |||||
| 分部间抵销(元) | -50,458.71 | - | -55,045.88 | - | - |
| 药品制剂(元) | 1,043,942,205.80 | - | 1,049,958,969.24 | - | 1,057,488,474.86 |
| 医疗器械(元) | 42,533,388.90 | 106,335,086.06 | 54,199,337.27 | 108,487,642.55 | 51,705,108.20 |
| 妇科用药(元) | - | 60,799,150.67 | - | 56,509,502.56 | - |
| 精神神经系统类(元) | - | 131,087,651.20 | - | 115,460,638.36 | - |
| 慢性肾病类(元) | - | 242,041,549.65 | - | 235,660,249.78 | - |
| 皮肤病类(元) | - | 230,291,429.16 | - | 199,926,560.70 | - |
| 糖尿病类(元) | - | 391,942,509.83 | - | 352,905,485.18 | - |
| 消化系统类(元) | - | 238,764,538.90 | - | 220,694,603.66 | - |
| 心血管类(元) | - | 734,537,459.92 | - | 785,980,424.26 | - |
| 其他(元) | - | 1,311,643.91 | - | -1,347,690.11 | - |
| 其他治疗领域(元) | - | 164,060,298.84 | - | 145,637,372.27 | - |
| 毛利率(%) | |||||
| 分部间抵销(%) | 3.47 | - | 3.40 | - | - |
| 药品制剂(%) | 67.91 | - | 68.04 | - | 69.79 |
| 医疗器械(%) | 43.36 | 47.78 | 47.53 | 46.48 | 44.58 |
| 妇科用药(%) | - | 65.69 | - | 67.22 | - |
| 精神神经系统类(%) | - | 83.60 | - | 83.20 | - |
| 慢性肾病类(%) | - | 63.10 | - | 60.67 | - |
| 皮肤病类(%) | - | 53.70 | - | 52.23 | - |
| 糖尿病类(%) | - | 83.15 | - | 84.34 | - |
| 消化系统类(%) | - | 50.84 | - | 50.33 | - |
| 心血管类(%) | - | 81.92 | - | 83.54 | - |
| 其他(%) | - | 64.16 | - | -44.14 | - |
| 其他治疗领域(%) | - | 53.05 | - | 48.64 | - |
| 收入构成(%) | |||||
| 分部间抵销(%) | -0.09 | - | -0.10 | - | -0.08 |
| 药品制剂(%) | 94.09 | - | 93.21 | - | 92.97 |
| 医疗器械(%) | 6.00 | 6.48 | 6.89 | 7.01 | 7.12 |
| 妇科用药(%) | - | 2.70 | - | 2.53 | - |
| 精神神经系统类(%) | - | 4.57 | - | 4.17 | - |
| 慢性肾病类(%) | - | 11.17 | - | 11.67 | - |
| 皮肤病类(%) | - | 12.49 | - | 11.50 | - |
| 糖尿病类(%) | - | 13.73 | - | 12.57 | - |
| 消化系统类(%) | - | 13.68 | - | 13.18 | - |
| 心血管类(%) | - | 26.12 | - | 28.27 | - |
| 其他(%) | - | 0.06 | - | 0.09 | - |
| 其他治疗领域(%) | - | 9.01 | - | 9.00 | - |
| 毛利构成(%) | |||||
| 分部间抵销(%) | 0.00 | - | 0.00 | - | 0.00 |
| 药品制剂(%) | 96.09 | - | 95.10 | - | 95.34 |
| 医疗器械(%) | 3.91 | 4.62 | 4.91 | 4.89 | 4.66 |
| 妇科用药(%) | - | 2.64 | - | 2.55 | - |
| 精神神经系统类(%) | - | 5.70 | - | 5.20 | - |
| 慢性肾病类(%) | - | 10.52 | - | 10.62 | - |
| 皮肤病类(%) | - | 10.01 | - | 9.01 | - |
| 糖尿病类(%) | - | 17.03 | - | 15.90 | - |
| 消化系统类(%) | - | 10.38 | - | 9.94 | - |
| 心血管类(%) | - | 31.92 | - | 35.41 | - |
| 其他(%) | - | 0.06 | - | -0.06 | - |
| 其他治疗领域(%) | - | 7.13 | - | 6.56 | - |